BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 16, 2007
View Archived Issues
Snapshots on AMD-11070, a novel small-molecule CXCR4 inhibitor
Read More
Immune responses expanded with Remune(R) during HIV treatment interruption
Read More
Atorvastatin may reduce cardiovascular events more than simvastatin
Read More
Enterotoxigenic Escherichia coli vaccine reduces diarrhea severity in double-blind trial
Read More
Astellas Pharma updates clinical progress of YM-155
Read More
Recent Lilly and Merck patents describe new antidiabetic agents
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Recent patents cover new therapeutic agents for cancer
Read More
Novel treatments for inflammatory disorders claimed in recent patents
Read More
Roche to terminate MAXY-VII collaboration with Maxygen
Read More
Adherex outlines achievements of 2006, updates goals for 2007
Read More
IRB approval for phase III study of crofelemer in HIV-associated diarrhea
Read More
FDA awards orphan drug status to cethromycin for anthrax infection
Read More
Curis selects CUDC-101 from targeted cancer drug development platform
Read More
Tragara closes Series A financing to support oncology and inflammatory programs
Read More
Nektar advances PEG-irinotecan into phase I
Read More
Avigen cleared to begin phase II with AV-650 for spasticity and muscle spasms
Read More
Difimicin cleared to advance into phase III
Read More
Curalogic initiates phase III trial for oral ragweed therapy
Read More
GV-1001 studied with chemotherapy for inoperable pancreatic cancer
Read More
TG-1042 for cutaneous B-cell lymphoma in phase II trial
Read More
C1-INH meets primary endpoint in acute HAE study
Read More
Phase II results for Aridol in COPD
Read More
Identification of a novel cdk5/p25 inhibitor potentially useful for Alzheimer's disease
Read More
Transtec more effective and better tolerated than morphine
Read More
Japanese launch for Copegus in chronic hepatitis C
Read More
